Lacerta Therapeutics Is A Clinical Stage Gene Therapy Company Based In Alachuafloridafounded In 2017The Company Is Focused On Discovering And Developing Aav Based Therapiesparticularly For Central Nervous System And Lysosomal Storage Diseasesthey Utilize Proprietary Aav Vector Technologies To Create Innovative Treatment Optionsincluding Gene Replacement And Vectorized Antibody Delivery The Company Operates From A Custom Built R&D Laboratory Facility Designed To Support The Advancement Of Their Gene Therapy Candidateswith A Team Of Approximately 55 Employeeslacerta Therapeutics Emphasizes Innovation And Research In Its Operationsthe Company Has Successfully Raised Around $30 25 Million In Fundingwith Notable Investors Including Sarepta Therapeutics
No conferences found for this company.
| Company Name | Lacerta Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
